Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Exosome Mediated Multidrug Resistance in Cancer.

Exosome: Emerging Biomarker in Breast Cancer

Exosomes: A New Pathway for Cancer Drug Resistance

Exosome: a novel mediator in drug resistance of cancer cells.

Intercellular transfer of multidrug resistance mediated by extracellular vesicles

Extracellular vesicles in anti-tumor drug resistance: Mechanisms and therapeutic prospects

Extracellular Vesicles in Cancer Drug Resistance: Mechanistic Insights and Therapeutic Implications

The Role and Clinical Applications of Exosomes in Cancer Drug Resistance

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Exosome: Function and Role in Cancer Metastasis and Drug Resistance

The Roles of Exosomes in Cancer Drug Resistance and Its Therapeutic Application

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications

Exosomes and breast cancer drug resistance

Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers

Extracellular vesicles in breast cancer drug resistance and their clinical application

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors

Exosomes and cancer immunotherapy: A review of recent cancer research

The Role of Tumor‐Derived Extracellular Vesicles in Drug Resistance in Urologic Cancers

Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance

Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication